Related Experiment Video
Updated: Feb 25, 2026

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
Published on: May 1, 2020
ATP-competitive, marine derived natural products that target the DEAD box helicase, eIF4A
Joseph Tillotson1, Magdalena Kedzior1, Larissa Guimarães2
1Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, 1703 East Mabel Street, P.O. Box 210207, Tuscon, AZ 85721, United States.
Abstract:
Activation of translation initiation is a common trait of cancer cells. Formation of the heterotrimeric eukaryotic initiation factor F (eIF4F) complex is the rate-limiting step in 5' m7GpppN cap-dependent translation. This trimeric complex includes the eIF4E cap binding protein, the eIF4G scaffolding protein, and the DEAD box RNA helicase eIF4A. eIF4A is an ATP-dependent helicase and because it is the only enzyme in the eIF4F complex, it has been shown to be a potential therapeutic target for a variety of malignancies. To this end, we have used a simple ATPase biochemical screen to survey several hundred marine and terrestrial derived natural products. Herein, we report the discovery of two natural products from marine sources, elisabatin A (1) and allolaurinterol (2), which show low µM inhibition of eIF4A ATPase activity. Enzymological analyses revealed 1 and 2 to be ATP-competitive, and cellular evaluations showed reasonable cytotoxicity against A549 (lung cancer) and MDA-MA-468 (breast cancer) cell lines. However, only compound 2 showed potent inhibition of helicase activity congruent with its ATPase inhibitory activity.
Insights
Marine natural products elisabatin A and allolaurinterol inhibit eukaryotic initiation factor 4A (eIF4A) ATPase activity. These compounds show cytotoxicity against cancer cells, with allolaurinterol also potently inhibiting eIF4A helicase activity.
Area of Science:
- Biochemistry
- Molecular Biology
- Marine Natural Products Chemistry
Background:
- Cancer cells exhibit activated translation initiation, crucial for proliferation.
- The eukaryotic initiation factor 4F (eIF4F) complex, particularly the eIF4A helicase, is a rate-limiting step and a potential therapeutic target.
Purpose of the Study:
- To discover novel inhibitors of eIF4A ATPase activity from natural product libraries.
- To evaluate the biochemical and cellular effects of identified compounds.
Main Methods:
- Biochemical ATPase activity screen of marine and terrestrial natural products.
- Enzymological analyses to determine inhibition kinetics (ATP-competitive).
- Cytotoxicity assays against A549 (lung) and MDA-MA-468 (breast) cancer cell lines.
- Assessment of eIF4A helicase activity inhibition.
Main Results:
- Identified elisabatin A and allolaurinterol from marine sources with low µM inhibition of eIF4A ATPase activity.
- Both compounds demonstrated ATP-competitive inhibition.
- Compounds showed moderate cytotoxicity against tested cancer cell lines.
- Allolaurinterol exhibited potent inhibition of eIF4A helicase activity, correlating with ATPase inhibition.
Conclusions:
- Elisabatin A and allolaurinterol are promising marine-derived inhibitors of eIF4A.
- Allolaurinterol's dual inhibition of ATPase and helicase activities makes it a strong candidate for further anticancer drug development targeting translation initiation.
Related Concept Videos
DNA Helicases
ATP Synthase: Mechanism
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Actin Filament Depolymerization
In F-actin, the ADF/cofilin proteins...
ATP Synthase: Structure

